Risk factors for device-related pressure injury include fragile skin and prone positioning during mechanical ventilatory support
One in Nine May Get Delayed Large Local Reaction After Moderna Vaccine
Higher risk seen among women and among individuals aged 30 to 69 years
Debt Valuation of Private Equity-Backed Dermatology Groups Down
Valuation of debt instruments significantly decreased from May to August 2019, followed by further decrease during COVID-19
COVID-19 Proning Teams Benefit From Wound Care Specialist Nurse
Findings show inclusion significantly cuts odds of pressure injuries in patients hospitalized with severe COVID-19
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
COVID-19 Weakly Correlated With Chilblains Incidence
However, only 3.7 percent of the 456 patients with chilblains were positive for SARS-CoV-2
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID’d
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
Skin Reactions Usually Mild After COVID-19 Vaccination
Most common were delayed large local reactions, followed by local injection site reactions, urticarial eruptions, morbilliform eruptions
Cutaneous Findings Described for Children With MIS-C
Cutaneous findings varied among patients; annular plaques in the proximal medial lower extremities were common
- Page 1 of 2
- 1
- 2